Meridiem Capital Partners LP Rx Sight, Inc. Transaction History
Meridiem Capital Partners LP
- $1.56 Trillion
- Q3 2025
A detailed history of Meridiem Capital Partners LP transactions in Rx Sight, Inc. stock. As of the latest transaction made, Meridiem Capital Partners LP holds 174,014 shares of RXST stock, worth $1.69 Million. This represents 0.1% of its overall portfolio holdings.
Number of Shares
174,014Holding current value
$1.69 Million% of portfolio
0.1%Shares
1 transactions
Others Institutions Holding RXST
# of Institutions
170Shares Held
32.1MCall Options Held
64.6KPut Options Held
62.9K-
Black Rock Inc. New York, NY2.4MShares$23.4 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.19MShares$21.3 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.15MShares$20.9 Million0.0% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY1.83MShares$17.8 Million0.01% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI1.75MShares$17.1 Million0.02% of portfolio
About RxSight, Inc.
- Ticker RXST
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 27,638,900
- Market Cap $269M
- Description
- RxSight, Inc., a medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. T...